Registration and Morning Coffee

Opening Remarks From The Organizer and Chair

Health AI Development & Testing with Digital Twins

Discover how digital twins can revolutionize the health AI product development life cycle! Let's delve into how digital twins can streamline validation, slash development and validation expenses, and ensure product viability, resulting in accelerated launches.

Digital twins are digital simulators of physical objects, systems, or processes, leveraging real-time data to model their behavior, performance, and unique attributes. Although the potential of AI to drive innovation in healthcare is promising, the current product development life cycle for such innovations involves multiple intertwined validation and testing stages to ensure their safety, effectiveness, and applicability across varied populations or users. Consequently, this elongates the development life cycle compared to that of typical digital products, making it both time-consuming and more expensive.

Digital twins could empower healthcare product developers to explore novel concepts and AI technologies within a virtual setting, using virtual prototypes that come at a fraction of the cost and risk compared to physical trials or real-world studies.
Bullet points:

• Intro to Simulation & DTs in Health AI Development
• Understanding Health AI Development Process
  • Regular Lifecycle
  • Challenges in traditional development approaches for AI
• How Digital Twins Can Boost the Health AI Development Process
  • Simulation of a Digital Twin Powered Development Process
  • Designing and Testing an Effective Digital Twin
• Case Studies & Examples
  • Success Stories & Lessons Learnt
  • Suggestions for Best Practices
• What Next? Future Trends

Ghaith Sankari

Head of Global Digital Health Data Science

Bayer

Paula Sandrak

Product Strategist (dHealth & Health AI)

Bayer

10,000 Prompts, 367 Oncologists: Key Trends in Cancer

Marcos Oliveira

A deep dive into 10,000 questions made by 367 oncologists to a machine reveals the real-world trends in cancer care.

My talk will focus on:

• genAI adoption by oncologists compared to the other specialties and across countries
• Persona of the oncologist using AI
• How are oncologists using AI
• Top science most consumed by oncologists
• Insights into oncologists' questions regarding the major trends in oncology, including novel products

A real-world, data-driven approach, offering an unbiased perspective on AI adoption by HCPs and oncology’s hottest topics.

Marcos Oliveira

Senior Business Developer

Tonic App

How to Implement Digital Health Partnerships Between Corporate and Start-ups?

Dan Ma

Join us for an illuminating keynote on implementing successful digital health partnerships between corporates and start-ups, where we'll explore creating win-win concepts, measuring success, and avoiding common pitfalls.

• How to set-up a win-win concept
• How to measure success
• How to avoid common mistakes 

Dan Ma

Head of Innovation & New Commercial Partnerships | Head Sandoz Innovation Lab Germany

Sandoz

Coffee-Break

You Are Not Alone: The Challenges to Deliver Digital Health Solutions from Idea to Implementation

Atif Elahi

Join us for a dynamic session that uncovers the key challenges in delivering digital health solutions from concept to market. Findings from evidence-based research will highlight gaps and opportunities in the industry’s existing frameworks and processes, which are currently limiting the efficiency and effectiveness of digital health execution. This session will provide a detailed analysis of why many current pharma practices struggle to succeed and offer actionable recommendations to streamline the path from innovation to scalable digital health solutions.

Atif Elahi

Digital Health Business Leader

Roche

Roundtable Discussion: Building a Vibrant Ecosystem for Healthcare Innovation

Mohamed-Ramzi Temanni

Moderator: Mohamed-Ramzi Temanni, Senior Director, Head of AI for Systems Biology, Data Science and Digital Health,
Johnson & Johnson Innovative Medicine

All delegates will have 40 minutes to discuss
the below topics:

Creating a thriving ecosystem for healthcare innovation necessitates a holistic approach that integrates advanced technology, fosters multidisciplinary talent development, and encourages robust public-private collaborations. This ecosystem is essential for driving transformative advancements in healthcare and enhancing the quality of care.

Lunch

Enjoy the Portuguese Cuisine!

Scaling Best Practices in Digital Health: Leveraging AI for Enhanced Care and Efficiency

Charles Vivien

In the rapidly evolving landscape of digital health, success depends not only on innovation but also on the ability to scale best practices across teams and organizations. Join us for an insightful keynote where Wegrow will explore how artificial intelligence (AI) can be utilized to share and amplify proven strategies within the healthcare sector.

Using real-world examples from global leaders such as Merck, Sandoz, Organon, Bayer we’ll showcase how these organizations are optimizing operations and addressing the growing demand for personalized, data-driven healthcare solutions. Discover how your organization can stay ahead in the digital health revolution by adopting scalable best practices that drive both efficiency and operational excellence.

Charles Vivien

Vice President of Global Sales

Wegrow

AstraZeneca Generative AI Upskilling at Scale: Our journey from 2023 to 2024

Bonnie Cheuk

From 2023 to 2024, Dr Bonnie Cheuk has been leading "Thriving in the age of AI: the AZ Generative AI Acceleration Program" inviting the whole workforce (including R&D Digital Health team) to understand AI/generative AI, data and AI ethics and human skills required to collaborate with AI. Through a series of interactive keynotes, hands-on lab sessions, strategic thinking workshops, reflection exercises, over 8000+ employees are thinking together, experimenting together and learning together. Come to this session to find out more and check out the background information here: https://www.astrazeneca.com/media-centre/articles/2024/upskilling-AI.html

Bonnie Cheuk

Global Capability Development Leader - Digital, Data, AI and Learning Agility

AstraZeneca

NEURii Project: Revolutionise Healthcare for Dementia Patients With Innovative Digital Tools and Cross-Ecosystem Collaboration

Ricardo Sáinz Fuertes

Combine individual-centric approach with pioneering technology capabilities through strategic partnerships to better address evolving needs of your patients.
Learn how digital therapeutics can support personalised care and enhance the quality of life for dementia patients and their caregivers.

Abstract:
In the realm of healthcare, addressing the multifaceted needs of dementia patients requires innovative approaches that integrate technology, compassionate care, and strategic partnerships. NEURii stands at the forefront of this endeavour, poised to transform the landscape of dementia care through a synergistic fusion of Eisai’s human Health Care (hhc) concept, the philanthropic vision of Gates Ventures, the ambition to transform the way diseases are identified and treated of LifeArc, the vision to enhance health and care interactions by using large scale data and advanced analytics of Health Data research UK (HDRUK), and The University of Edinburgh’s pioneering capabilities across health data, AI and neurodegeneration facilitated by the innovative partnership support of its commercial arm, Edinburgh Innovations.

Eisai's hhc concept redefines healthcare delivery by placing the individual at the center, emphasizing personalized care, proactive interventions, and seamless integration of digital therapeutics. This holistic approach resonates profoundly in dementia care, where individualized support, cognitive stimulation, and caregiver engagement are paramount. Leveraging Eisai's hhc, NEURii envisions a future where dementia patients experience enhanced quality of life, improved symptom management, and empowered participation in their care journey.

Central to NEURii's mission is a steadfast commitment to dementia patients, caregivers, and healthcare stakeholders. By harnessing the collective power of Eisai's hhc concept, the support of Gates Ventures, LifeArc and HDRUK, and the University of Edinburgh’s capabilities, NEURii aspires to usher in a new era of compassionate, person-centered dementia care with holistic focus on prevention, prediction, diagnosis and treatment.

Together, we embark on a journey fuelled by innovation, collaboration, and unwavering dedication to improving the lives of those affected by dementia.

Key Takeaways:

• NEURii Project integrates Eisai’s hhc concept, the philanthropic mission of Gates Ventures, the ambition of LifeArc and the vision of HDR UK to leverage big data with The University of Edinburgh’s capabilities to revolutionize dementia care.
• Strategic partnership with Gates Ventures, HDRUK and LifeArc provides powerful complement of expertise and national and international ambition.
• Eisai’s hhc emphasizes personalized care, proactive interventions, and digital therapeutics.
• NEURii Project is committed to enhancing the quality of life for dementia patients and caregivers through innovation and collaboration.

Dr Ricardo Sainz Fuertes
Global Director Digital Health Solutions
NEURii Program Director
Eisai

Drug + Digital as the Future Standard of Care? Considerations for Achieving Success with DTx Drug Companion Solutions

Pete Brockmeier

Across many industries, modern products include a digital component, enabling personalization, enhanced experiences, and generating valuable data for customers and companies.

In medicine, “drug + digital" offerings can similarly improve patient experiences and outcomes, leveraging clinically validated DTx companion apps to simplify and optimize medication use. However, the adoption of these solutions has been challenged by regulatory and distribution complexities and unclear or lacking incentives for key stakeholders in the value chain.

This talk will explore practical strategies to overcome these hurdles and effectively deliver DTx drug companion apps to patients, unlocking their potential benefits.

Pete Brockmeier
Global Associate Director, Digital Health
Novo Nordisk

Coffee-Break

Stand-Up Discussion

In this interactive Stand-up Conversation session, the audience will be divided into 4 groups, each assigned to a different discussion topic. Every group will engage in an open dialogue, brainstorming ideas and sharing insights related to their assigned theme. A flipchart will be provided at each station for participants to capture key points and solutions. After the discussions, each group will present their conclusions to the larger audience, fostering a collaborative exchange of ideas and diverse perspectives across all topics. It's a dynamic way to dive deeper into key issues while engaging everyone in the room!

Lessons Learned from Implementing Digital Health Technologies into Clinical Trials

Charlotte Sauter

This presentation will provide insights and lessons learned from integrating Digital Health Technologies (DHTs), such as wearables, into clinical trials. Key points include understanding the usability of DHTs, recognizing the patient's involvement, and identifying pitfalls and mitigation strategies. Additionally, the presentation will touch upon the FDA Guide for Remote Data Acquisition in Clinical Investigations. Join to explore the critical roles of patients, sites, and sponsors in the context of DHTs in clinical trials.

Patient Centric Approach
- Device burden and patient-related factors.

The Clinical Site's Role
- Challenges faced by sites during DHT implementation.

Sponsor Responsibilities
- Designing trials that optimize data collection without imposing burden.

Charlotte Sauter
Senior Digital Health Scientist
Lundbeck

Panel Discussion: Synergies in Action: Real-World Wins & Lessons in Digital Health Partnerships

Dan Ma

This session will bring together dynamic female leaders from across the digital health landscape, who will share their experiences in forging successful partnerships that drive real-world impact. Expect insightful conversations on how collaboration has been pivotal in overcoming challenges, fostering innovation, and delivering scalable solutions in healthcare.
Moderator:
🎤 Dan Ma, Head of Innovation & New Commercial Partnerships | Head Sandoz Innovation Lab Germany, Sandoz

Panelists:
🎙 Gemma Malla Salomó, Head of Digital Medicines Iberia & Business Unit Head Ophthalmology, Angelini Pharma
🎙Dr. Friderike Bruchmann, Co-Founder & CEO at XO Life
🎙Katherine Ossenkopp, Country Manager Germany at Future4Care
🎙Farnaz Behroozi, Ph.D., Head of Pharma at Huma
🎙Lu Zheng, Head of Value Based Partnerships and Digital Health, Europe & Canada, Takeda

This 40-minute panel will delve into the dynamic world of digital health collaborations. Dan brings a wealth of experience in forging strategic partnerships that drive innovation and growth.

Joining Dan are industry leaders who will share their expertise and perspectives on the critical role of partnerships in advancing digital health solutions. They will explore successful collaboration models, the challenges of aligning diverse stakeholders, and strategies to create synergies that enhance patient outcomes and operational efficiencies.

Prepare for a compelling discussion that will provide actionable insights and inspire new ways to leverage partnerships in the ever-evolving digital health landscape. Let's dive in!

Moderator

Dan Ma

Head of Innovation & New Commercial Partnerships and Head of the Sandoz Innovation Lab in Germany

Sandoz

Cocktail Reception with Portuguese Wine Tasting

Refresh yourself after a full day of learning and take the opportunity to close important partnerships for your business.